National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

PADRE 965.10
Pan-DR epitope (PADRE) 965.10 is a helper peptide. PADRE peptides have been shown the capacity to deliver help for antibody responses in vivo. They were also found to be able to provide significant helper T-cell activity in vivo. Acts as an adjuvant. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:15 Amino Acid Helper Peptide
Code name:PADRE 96510



Previous:paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, paclitaxel poliglumex, paclitaxel vitamin E-based emulsion formulation, paclitaxel-loaded polymeric micelle
Next:Palestrol, palifermin, Pallace, palladium Pd 103, palladium-bacteriopheophorbide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov